揭示前列腺癌患者雄激素剥夺治疗的代谢并发症——我们接下来该何去何从？ - Suppr | 超能文献

Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?

作者信息

Pinthus Jehonathan H

机构信息

Department of Surgery, Division of Urology, McMaster University, Ontario, Canada.

出版信息

J Urol. 2015 Jun;193(6):1882-3. doi: 10.1016/j.juro.2015.03.070. Epub 2015 Mar 17.

DOI:10.1016/j.juro.2015.03.070

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Uncovering the metabolic complications of androgen deprivation therapy in patients with prostate cancer--where do we take it next?揭示前列腺癌患者雄激素剥夺治疗的代谢并发症——我们接下来该何去何从？

J Urol. 2015 Jun;193(6):1882-3. doi: 10.1016/j.juro.2015.03.070. Epub 2015 Mar 17.

2

Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.接受原发性雄激素剥夺治疗的临床局限性前列腺癌患者患糖尿病的风险。

J Urol. 2015 Jun;193(6):1956-62. doi: 10.1016/j.juro.2014.12.027. Epub 2014 Dec 15.

3

Metabolic complications of androgen deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗的代谢并发症

J Urol. 2009 May;181(5):1998-2006; discussion 2007-8. doi: 10.1016/j.juro.2009.01.047. Epub 2009 Mar 14.

4

Emerging cardiometabolic complications of androgen deprivation therapy.雄激素剥夺治疗的新兴心脏代谢并发症。

Aging Male. 2010 Mar;13(1):1-9. doi: 10.3109/13685530903410625.

5

Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications.前列腺癌患者雄激素剥夺治疗的不良反应：聚焦代谢并发症

Hormones (Athens). 2017 Apr;16(2):115-123. doi: 10.14310/horm.2002.1727.

6

Androgen deprivation therapy for prostate cancer: new concepts and concerns.前列腺癌的雄激素剥夺治疗：新概念与新问题

Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):247-54. doi: 10.1097/MED.0b013e32814db88c.

7

Long term androgen deprivation therapy in prostate cancer.前列腺癌的长期雄激素剥夺治疗

BMJ. 2008 Sep 22;337:a1361. doi: 10.1136/bmj.a1361.

8

Complications of androgen-deprivation therapy in prostate cancer: the other side of the coin.前列腺癌雄激素剥夺治疗的并发症：问题的另一面。

BJU Int. 2009 Apr;103(8):1020-3. doi: 10.1111/j.1464-410x.2008.08293.x.

9

The effects of androgen deprivation therapy on lipid metabolism and body composition in Japanese patients with prostate cancer.雄激素剥夺疗法对日本前列腺癌患者脂代谢和身体成分的影响。

Jpn J Clin Oncol. 2011 Apr;41(4):577-81. doi: 10.1093/jjco/hyr005. Epub 2011 Feb 4.

10

Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.前列腺癌雄激素剥夺治疗期间的糖尿病和心血管疾病

J Clin Oncol. 2006 Sep 20;24(27):4448-56. doi: 10.1200/JCO.2006.06.2497.

引用本文的文献

1

Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2).前列腺癌综合生活方式改善计划2（CLIPP2）的可行性和早期疗效研究方案。

Contemp Clin Trials Commun. 2021 Jan 13;21:100701. doi: 10.1016/j.conctc.2021.100701. eCollection 2021 Mar.

2

Risk Analysis of Prostate Cancer Treatments in Promoting Metabolic Syndrome Development and the Influence of Increased Metabolic Syndrome on Prostate Cancer Therapeutic Outcome.前列腺癌治疗促进代谢综合征发生的风险分析及代谢综合征增加对前列腺癌治疗效果的影响。

Horm Cancer. 2018 Aug;9(4):278-287. doi: 10.1007/s12672-018-0335-8. Epub 2018 Jun 9.